Navigation Links
In troubled economic times, BioSquare 2009 successfully serves as business and innovation starter
Date:3/30/2009

Lyon, France, March 30, 2009 / b3c newswire / - The 2009 edition of the BioSquare business conference was held March 9-11 in Lyon. For three days, the 343 companies in attendance, including 11 big pharma companies, held some 2,500 business meetings. The conference created real dynamics in a difficult economic context by offering biotech and pharma company managers a solid chance to develop business opportunities, create partnerships and get acquainted with new technologies in booming biotech industries.

BioSquare 2009 geared to the biotech market and companies 

“For Biotech companies, the financing of innovation is essential, which may be quite a challenge in the current economic climate. Finding the right partners will be an even more critical factor of success. In just three days, BioSquare 2009 served as a place for business exchanges leading to international partnerships,” said Bernadette Guagliata, BioSquare’s CEO.
In order to maintain any kind of leadership in innovation during these difficult times, it is necessary to convince investors, to communicate knowledge and know-how effectively, to determine which sectors are most favourable in terms of growth, to set up strategic partnerships, and to know how to sign the right contract… By enabling biotech companies to get advice from renown experts in these key areas, through its thematic sessions, BioSquare has positioned itself as an event with high added value.
“With the ability to create synergies among the various technologies (high-tech, cleantech, biotech), to present young biotech companies, to cross-match information...BioSquare becomes a relevant business conference,” states Albin Jourda, CEO of Gallium Moore, a merger/acquisition consulting firm specialised in information technology, biotech and cleantech.

BioSquare 2009 sets up meetings, partnerships and businesses 

With more than 2,500 business meetings, the 343 biotech firms represented by more than 520 delegates turned BioSquare into an effective business and trade platform. 
On Tuesday alone, 11 pharmaceutical leaders including Johnson&Johnson, GSK, Bayer, Sanofi-Aventis and 20 Biotech companies including Ipsogen, Theregen, Biomay, Ascendis pharma– had the chance to expose their know-how and R&D programmes, with the evidence that their technologies need others to exist, grow and find the right market.
Gilles Rubinstenn, Managing Director of the Pierre-Gilles de Gennes Foundation, notes: “We got involved in preparing the thematic programme for BioSquare 2009 and we were especially satisfied with the return on this investment: The Foundation’s main objective is to bring the academic research sector together with innovative firms to set up projects with high added value. During these three days, 40 face-to-face meetings with biotech companies left us with 25 serious partnership prospects.”

BioSquare 2009 talks innovations and new applications for Biotech technologies  

For the 2009 edition’s scientific and strategic programme, BioSquare decided to give the floor to booming innovative industries like cleantech, stem cells and theranostics.
Regarding the workshop on theranostics, Marc Essodaigui, Vice President Marketing & Sales, Europe & Asia at Ipsogen, notes: “Theranostics as a concept has been around a long time but is coming into real applications now. A better understanding of diseases allows more targeted therapies; and these need increasingly high-performance diagnostic tools. The pharma industry and the biotechs are therefore working together, especially on cancer, where patient monitoring is essential and diagnostic tools have real benefit.” In the current economic situation, “The biotechs that have innovative diagnostic technologies have more of a trump card to play, especially in supporting pharma activity for clinical development,” he concludes.

BioSquare in 2010 

While fewer delegates attended the 2009 edition, activity remains strong. BioSquare 2009 shows that the biotechs are standing up to the crisis. “The continuous progress and discoveries in the field of biotechnology area - more than ever – opening new opportunities for Health, Agriculture, Energy-management and Pollution-control” As Bernadette Guagliata noted at the opening session, “This makes BioSquare even more important, because we can effectively and efficiently be a support, to optimise and stimulate the process of partnering and networking at an international level.”
BioSquare 2010 edition will be held in Switzerland in an entirely overhauled format for more effectiveness, more contacts and more deals...

Press contact

Frédéric Le Gall 
fred@tamaco.fr 
+33 (0)6 64 28 89 00

BioSquare Contact

Bernadette Guagliata
bernadette.guagliata@bioevents.eu


'/>"/>
b3c newswire

Related biology news :

1. Hatchery fish outnumber wild chinook salmon in troubled fall run
2. Shark attacks decline worldwide in midst of economic recession
3. Capillary mats labor-saving, economical alternative to hand watering
4. Basic research critical to Americas economic recovery
5. Study says middle class coral reef fish feel the economic squeeze
6. First-ever socioeconomic study on coral reefs points to challenges of coastal resource management
7. Top scientific meeting urges coordinated response to economic and environmental crises
8. New studies find global warming will have significant economic impacts on Florida coasts
9. Economic value of insect pollination worldwide estimated at 153 billion euros
10. Book breaks new ground in the study of economics and forest threats management
11. Scripps study sets high economic value on threatened Mexican mangroves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed Anwar ... the prestigious international IAIR Award for the most innovative high security ePassport ... ... Maldives Immigration Controller General, Mr. ... on the right) have received the IAIR award for the "Most innovative ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is ... and 8th June 2018 in San Francisco, CA. The Summit brings together current and ... distinguished CEOs, board directors and government officials from around the world to address key ...
(Date:10/11/2017)... a leading provider of patient support solutions, has announced the ... which will launch this week. The VMS CNEs will address ... enhance the patient care experience by delivering peer-to-peer education programs ... to help women who have been diagnosed and are being ... ...
(Date:10/11/2017)... Tbilisi, Georgia (PRWEB) , ... October 11, 2017 , ... ... disaster, taking the lives of over 5.5 million people each year. Especially those living ... the greenovative startup Treepex - based in one of the most pollution-affected countries globally ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
Breaking Biology Technology: